Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 212,851 | 262,438 | 239,876 | 225,449 | 183,497 |
| Receivables | 237,268 | 240,009 | 239,385 | 213,908 | 232,041 |
| Inventories | 93,537 | 93,602 | 90,881 | 88,023 | 80,234 |
| Other current assets | 75,169 | 80,891 | 75,947 | 80,484 | 59,573 |
| TOTAL | $618,825 | $676,940 | $646,089 | $607,864 | $555,345 |
| Non-Current Assets | |||||
| PPE Net | 845,130 | 826,835 | 788,218 | 748,793 | 688,150 |
| Intangibles | 1,307,330 | 1,257,412 | 1,265,195 | 1,269,445 | 1,276,689 |
| Other Non-Current Assets | 125,597 | 129,911 | 145,225 | 179,435 | 215,590 |
| TOTAL | $2,278,057 | $2,214,158 | $2,198,638 | $2,197,673 | $2,180,429 |
| Total Assets | $2,896,882 | $2,891,098 | $2,844,727 | $2,805,537 | $2,735,774 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 239,030 | 210,042 | 33,743 | 25,051 | 24,133 |
| Accounts payable and accrued liabilities | 36,367 | 43,523 | 36,772 | 36,715 | 36,013 |
| Accrued Expenses | 118,809 | 125,309 | 106,548 | 114,725 | 108,809 |
| Other current liabilities | 32,718 | 26,293 | 27,480 | 23,268 | 32,714 |
| TOTAL | $512,510 | $500,775 | $302,837 | $302,528 | $290,366 |
| Non-Current Liabilities | |||||
| Long Term Debt | 303,681 | 312,260 | 476,367 | 484,998 | 493,697 |
| Deferred Revenues | 85,470 | 94,889 | 97,556 | 102,021 | 88,447 |
| Other Non-Current Liabilities | 133,392 | 132,446 | 155,580 | 157,544 | 149,615 |
| TOTAL | $437,078 | $444,448 | $631,864 | $642,542 | $643,312 |
| Total Liabilities | $949,588 | $945,223 | $934,701 | $945,070 | $933,678 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,681 | 67,839 | 68,129 | 68,176 | 67,922 |
| Common Shares | 766 | 762 | 760 | 754 | 751 |
| Retained earnings | 317,570 | 272,870 | 222,683 | 177,529 | 140,619 |
| Other shareholders' equity | 70,776 | 101,268 | 97,938 | 85,187 | 70,959 |
| TOTAL | $1,947,294 | $1,945,875 | $1,910,026 | $1,860,467 | $1,802,096 |
| Total Liabilities And Equity | $2,896,882 | $2,891,098 | $2,844,727 | $2,805,537 | $2,735,774 |